-
B287122-25mgPotent VEGFR-2 inhibitor.
-
B287122-50mgPotent VEGFR-2 inhibitor.
-
B287122-5mgPotent VEGFR-2 inhibitor.
-
B288665-10mgPotent cholesteryl ester transfer protein (CETP) inhibitor.
-
B288763-5mgInhibitor of HCV RNA-dependent RNA polymerase (RdRP: NS5b): potent hepatitis C virus (HCV) replication inhibitor.
-
B286702-10mgDual α9β1/α4β1 integrin inhibitor: preferentially mobilizes HSCs.
-
B286702-50mgDual α9β1/α4β1 integrin inhibitor: preferentially mobilizes HSCs.
-
B301564-500mlBorate buffer solution.
-
Ab175960-10mgBovine IgG Antibody: Isotype Control Antibody.
-
Ab175960-1mgBovine IgG Antibody: Isotype Control Antibody.
-
Ab175960-2mgBovine IgG Antibody: Isotype Control Antibody.
-
B419716-1000KUTest Specification Thromboplastin Specific Activity >:1200 units/mg powder Moisture 0 - 5% pH (1% solution) 6.5 - 7.5 Salt Environment Glycine, Sodium Choloride Recommended diluent for reconsitution 0.9%